Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database.
| Publicado en: | Breast Cancer Research Vol. 27; no. 1; pp. 1 - 21 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
4/9/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184382713&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184382713 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 4/9/2025 vid: 27 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 184382713 10.1186/s13058-025-02013-w 184382713 ppf: 1 ppct: 20 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database. aug: au: Han, Jinming Zhai, Xiaohan Tao, Xufeng Li, Yunming Zhao, Ziqi Yu, Zhan Dong, Deshi Yang, Shilei Lv, Linlin affil: https://ror.org/055w74b96 Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, 116024, Dalian, China sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|